Pediatric News

Gideon Koren, MD, FRCPC, FACMT, has been selected as the 2012 recipient of the Sumner Yaffe Lifetime Achievement Award in Pediatric Pharmacology and Therapeutics. Dr Koren is a pediatrician and toxicologist–clinical pharmacologist. He is Professor of Pediatrics, Pharmacology, Pharmacy, and Medical Genetics, and a Senior Scientist at The University of Toronto and the Hospital for Sick Children, and is Professor of Medicine, Pediatrics and Physiology-Pharmacology at the University of Western Ontario. He is the founder and director of the Motherisk Program in Toronto. He graduated from the Sackler School of Medicine at Tel Aviv University in 1974 and completed a pediatric residency in 1980 at Tel Aviv University, followed by 2 years of subspecialty training in pediatric nephrology, focusing on the renal damage caused by medications.Between 1982 and 1986 he completed his training in clinical pharmacology-toxicology at the University of Toronto and The Hospital for Sick Children. In 1985 he received a diploma in clinical toxicology from the American Board of Medical Toxicology.In 1985 Dr Koren founded, and has directed ever since, the Motherisk Program, a national counseling and research center for women and health professionals on the safety/risk of drugs, chemicals, radiation, infections during pregnancy, and lactation.His research programs are supported by the Canadian Institutes for Health Research, the National Institutes of Health, the March of Dimes, Physician Services Inc, Health Canada, the Ontario Ministry of Health, and the pharmaceutical industry.Dr Koren has published more than 1300 peer-reviewed scientific papers and 13 medical-scientific books, mostly in the field of human toxicology. He is the editor in chief of the international journal Therapeutic Drug Monitoring and Clinical Toxicology, and of the new peer-review journal Fetal Alcohol Research. He holds the Ivey Chair in Molecular Toxicology at the University of Western Ontario. Dr Koren has won numerous scientific awards in Canada and internationally, including the Rawls-Palmer award from the American Society for Clinical Pharmacology and Therapeutics (1977), and the Outstanding Achievement Award from the Canadian Society for Clinical Pharmacology. He has supervised in his laboratory trainees from more than 40 countries worldwide. Dr Koren discovered and described the use of hair analysis to detect long-term exposure to drugs of abuse (e.g., cocaine, heroin, crystal meth) both in adults and neonates, opening up tremendous opportunities to explain poisoning, toxicity, and effects on health and behavior. His group has documented for the first time that infants possess long-term memory for pain inflicted by circumcision at infancy.Catherine “Cathy” Crill, PharmD, BCPS, BCNSP (Memphis, Tennessee); Collin Hovinga, PharmD (Austin, Texas); and Donna Kraus, PharmD (Chicago, Illinois) were elected as Fellows of the American College of Clinical Pharmacy and will be recognized during a special ceremony on October 16, 2011, at the College's Annual Meeting in Pittsburgh, Pennsylvania. Recognition as a Fellow is awarded to ACCP members who have demonstrated a sustained level of excellence in clinical pharmacy practice and/or research. All three recipients are members of the Pediatric Pharmacy Advocacy and also serve on the editorial board of JPPT, the Journal of Pediatric Pharmacology and Therapeutics.Lea S. Eiland, PharmD, BCPS, was elected as Chair-Elect of the American Society of Health System Pharmacists (ASHP) Section of Clinical Specialists and Scientists. She will assume her role as Chair in June 2012. Lea is currently an Associate Clinical Professor of Pharmacy Practice with the Auburn University Harrison School of Pharmacy and is a Clinical Associate Professor of Pediatrics with the University of Alabama at Birmingham School of Medicine, Huntsville Regional Medical Campus. Lea graduated with her Doctor of Pharmacy from The University of Texas at Austin and The University of Texas Health Science Center at San Antonio. She completed an ASHP-accredited pediatric specialty residency at Texas Tech University Health Sciences Center at Amarillo. Lea joined the Auburn faculty in August 2002 and practices in general pediatrics in Huntsville, Alabama, at the Huntsville Hospital for Women & Children. Her interests include infectious disease and neurology. She joined the Pediatric Pharmacy Advocacy Group when she was a student and has been involved in various leadership roles with in PPAG, such as member of the board of directors, chair of the membership committee, and vice-president of member services. She is currently serving on the education, membership, and research committees.The American Academy of Pediatrics (AAP) and the Centers for Disease Control and Prevention revised previous recommendations for the use of the Tdap vaccine in children and adults.1 There is no longer any minimum interval between receiving a tetanus or diphtheria toxoid–containing vaccine and Tdap when given a short time apart. The AAP advises that a single dose of Tdap should be administered to children ages 7 through 10 who were underimmunized or who have an incomplete vaccine history. The AAP continues to recommend vaccination of adolescents, including pregnant adolescents. Pregnant women should also receive the vaccine.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.